<DOC>
	<DOCNO>NCT02732132</DOCNO>
	<brief_summary>The primary aim study investigate efficiency safety midazolam plus ketamine versus fentanyl plus propofol administered child undergo UGE determine appropriate sedation protocol .</brief_summary>
	<brief_title>A Comparison Sedation During Endoscopy Children</brief_title>
	<detailed_description>The patient give spray lidocaine 10 % topical pharyngeal anaesthesia sedation . Intravenous midazolam bolus dose 0.1 mg/kg ( maximum 4 mg ) administer Group A . Two minute later , ketamine bolus dose 1 mg/kg give intravenously . Patient response verbal tactile stimulus evaluate two minute ketamine application . Ketamine 0.5 mg/kg ( maximum 2 mg/kg ) add two minute interval adequate sedation achieve initially . The endoscopy process initiate endoscopist response . If patient agitated procedure start , ketamine 0.5 mg/kg single dose apply . Intravenous fentanyl bolus dose 1Âµg/kg administer Group B . Two minute later , propofol bolus dose 1 mg/kg give intravenously . Patient response verbal tactile stimulus evaluate two minute propofol application . Propofol 0.5 mg/kg add two minute interval adequate sedation achieve . The endoscopy process initiate endoscopist response . If patient agitated procedure start , propofol 0.5 mg/kg single dose apply . None patient give antidote process recovery . All patient monitor peripheral oxygen saturation , heart rate ( HR ) , respiratory rate , RSS procedure . Oxygen ( 2L/min ) nasal cannula give patient procedure . Hypoxia ( peripheral oxygen saturation &lt; 90 % 60 second ) , apnea , laryngospasm , tachycardia ( defined 30 % average heart rate age ) , bradycardia ( 30 % less average heart rate age ) , increase oral secretion ( enough warrant aspiration ) , flush , cough vomit assessed complication record .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<criteria>All patient ASA ( American Society Anesthesiologists ) physical status I II . Patients respiratory tract infection , glaucoma , psychosis , porphyria , hypertension , metabolic neurologic disease , increase intracranial pressure intracranial mass , patient know allergic drug use exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>